Launched on April 19, 2026, the ThyRed Base is a wearable device designed to deliver red and near-infrared light to the neck area in a hands-free format. It belongs to a growing category of light therapy devices that aim to bring photobiomodulation technology out of clinical or stationary setups and into everyday use.
At its core, the device uses specific wavelengths of light commonly studied in photobiomodulation research: 630nm, 660nm, and 830nm. These correspond to red light and near-infrared light, two ranges that interact with biological tissue in different ways due to their depth of penetration.
For general audiences, this type of technology is often referred to as red light therapy. It involves exposing the body to low-level light in specific wavelengths, with the goal of supporting natural cellular processes. For more technical audiences, this falls under photobiomodulation, a research field that studies how light influences mitochondrial activity and cellular energy production.
The ThyRed Base is designed as a neck-worn band with integrated LEDs positioned to deliver consistent light exposure to the cervical region. Unlike handheld devices or large light panels, it maintains a fixed distance and angle throughout use. This reduces one of the common issues in light therapy applications, which is variability in positioning and intensity during treatment sessions.
The combination of red light and near-infrared light reflects a standard approach in this field. Red wavelengths, such as 630nm and 660nm, are generally associated with more superficial tissue interaction. Near-infrared light, such as 830nm, can penetrate deeper into soft tissue. These differences are based on how light behaves as it passes through skin and biological structures.
The device distributes multiple LED sources across the neck band rather than relying on a single beam. This creates a broader and more uniform exposure area, which is intended to support consistent dosing during each session.
Wearable photobiomodulation systems have been gaining interest as the technology shifts toward home use. Research into LED-based devices has explored their feasibility, safety profile, and potential applications in areas such as skin health, recovery, and inflammation-related studies. However, outcomes in this field remain dependent on specific usage parameters, including wavelength, intensity, and duration.
It is important to note that photobiomodulation research is still evolving. While there are many promising laboratory and early clinical findings, effects can vary significantly between individuals and study designs. As a result, devices like the ThyRed Base are generally positioned in the wellness category rather than as medical treatments.
The launch of the ThyRed Base reflects a broader trend in wearable health technology, where light-based systems are being adapted into portable formats for more consistent and convenient use. Its focus on the neck area places it within a more targeted approach to light therapy, emphasizing localized exposure rather than full-body treatment systems.
As this category develops, future evaluation is likely to focus on usability, consistency of light delivery, and real-world user experience, alongside ongoing scientific research into photobiomodulation mechanisms and applications.